An Open Label Trial to Assess Safety, Tolerability, and Efficacy of the Fixed Dose Combination of GS-7977 and GS-5885 in HCV Genotype 1 Subjects Coinfected With HIV
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2017
Price : $35 *
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms ERADICATE
- 17 Apr 2016 Results assessing Sofosbuvir-based therapy among patients with mental health disease from SPARE, SYNERGY-A and ERADICATE studies, spresented at The International Liver Congress™ 2016.
- 01 Jan 2016 Results of pooled analysis of 2 phase II trials (NCT01805882 and NCT01878799) published in the AIDS
- 22 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.